Lancet report names Zoloft and Lexapro as best new-generation antidepressants
This article was originally published in Scrip
Executive Summary
Pfizer's SSRI Zoloft (sertraline and generics) and Forest Laboratories' SSRI Lexapro (escitalopram) have been named the best second-generation antidepressants in terms of safety and efficacy in a report published online in The Lancet (January 29th).